Cargando…

Liver transplantation in metastatic colorectal cancer: are we ready for it?

Colorectal cancer (CRC) is a prevalent disease worldwide, with more than 50% of patients developing metastases to the liver. Five-year overall survival remains modest among patients with metastatic CRC (mCRC) treated with conventional therapies however, liver transplantation in a highly selected pop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ros, Javier, Salva, Francesc, Dopazo, Cristina, López, Daniel, Saoudi, Nadia, Baraibar, Iosune, Charco, Ramon, Tabernero, Josep, Elez, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147684/ https://www.ncbi.nlm.nih.gov/pubmed/36879000 http://dx.doi.org/10.1038/s41416-023-02213-1

Ejemplares similares

Correction To: Liver transplantation in metastatic colorectal cancer: are we ready for it?
por: Ros, Javier, et al.
Publicado: (2023)

Encorafenib plus cetuximab for the treatment of BRAF-V600E-mutated metastatic colorectal cancer
por: Ros, Javier, et al.
Publicado: (2022)

Combined Treatment with Immunotherapy-Based Strategies for MSS Metastatic Colorectal Cancer
por: Baraibar, Iosune, et al.
Publicado: (2021)

Immunotherapy for Colorectal Cancer with High Microsatellite Instability: The Ongoing Search for Biomarkers
por: Ros, Javier, et al.
Publicado: (2023)

Advances in immune checkpoint inhibitor combination strategies for microsatellite stable colorectal cancer
por: Ros, Javier, et al.
Publicado: (2023)

The impact of clinical and translational research on the quality of life during the metastatic colorectal cancer patient journey
por: Rodriguez Castells, Marta, et al.
Publicado: (2023)

Unravelling the Complexity of Colorectal Cancer: Heterogeneity, Clonal Evolution, and Clinical Implications
por: Saoudi González, Nadia, et al.
Publicado: (2023)

Molecular subtypes and the evolution of treatment management in metastatic colorectal cancer
por: Martini, Giulia, et al.
Publicado: (2020)

BRAF, MEK and EGFR inhibition as treatment strategies in BRAF V600E metastatic colorectal cancer
por: Ros, Javier, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic in the early-onset colorectal cancer
por: Baraibar, Iosune, et al.
Publicado: (2023)

Sex and gender perspectives in colorectal cancer
por: Baraibar, I., et al.
Publicado: (2023)

A Comprehensive Biomarker Analysis of Microsatellite Unstable/Mismatch Repair Deficient Colorectal Cancer Cohort Treated with Immunotherapy
por: Élez, Elena, et al.
Publicado: (2022)

Current and emerging anti-angiogenic therapies in gastrointestinal and hepatobiliary cancers
por: Saoudi González, Nadia, et al.
Publicado: (2022)

332P Impact of the COVID-19 pandemic in the early-onset colorectal cancer (EOCRC)
por: Baraibar Argota, I., et al.
Publicado: (2022)

Isolated bilateral Tapia’s syndrome after liver transplantation: A case report and review of the literature
por: Bilbao, Itxarone, et al.
Publicado: (2016)

Targeted multiplex proteomics for molecular prescreening and biomarker discovery in metastatic colorectal cancer
por: Serna, Garazi, et al.
Publicado: (2019)

Are we ready for the ERAS protocol in colorectal surgery?
por: Kisielewski, Michał, et al.
Publicado: (2017)

Low Total Dose of Anti-Human T-Lymphocyte Globulin (ATG) Guarantees a Good Glomerular Filtration Rate after Liver Transplant in Recipients with Pretransplant Renal Dysfunction
por: Dopazo, Cristina, et al.
Publicado: (2018)

QTWiST analysis of the RECOURSE trial of trifluridine/tipiracil in metastatic colorectal cancer
por: Tabernero, Josep, et al.
Publicado: (2017)

Phase II study of necitumumab plus modified FOLFOX6 as first-line treatment in patients with locally advanced or metastatic colorectal cancer
por: Elez, E, et al.
Publicado: (2016)

High intrapatient variability of tacrolimus exposure associated with poorer outcomes in liver transplantation
por: Dopazo, Cristina, et al.
Publicado: (2022)

Establishment of patient-derived tumor organoids to functionally inform treatment decisions in metastatic colorectal cancer
por: Martini, G., et al.
Publicado: (2023)

Are we ready?()
por: Pedrosa, C.
Publicado: (2020)

A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients
por: Elez, Elena, et al.
Publicado: (2019)

Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer
por: Ciardiello, Davide, et al.
Publicado: (2021)

Epigenetic Inactivation of the BRCA1 Interactor SRBC and Resistance to Oxaliplatin in Colorectal Cancer
por: Moutinho, Catia, et al.
Publicado: (2013)

Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS‐mutant metastatic colorectal cancer
por: Elez, Elena, et al.
Publicado: (2019)

Phase II Open-Label Study to Assess Efficacy and Safety of Lenalidomide in Combination with Cetuximab in KRAS-Mutant Metastatic Colorectal Cancer
por: Siena, Salvatore, et al.
Publicado: (2013)

An overview of digital readiness in dentistry - are we ready?
por: Dickenson, Andrew, et al.
Publicado: (2022)

Are We Ready for Anything?
por: Neal-Boylan, Leslie
Publicado: (2020)

Are We Ready for Migrastatics?
por: Solomon, Jonathan, et al.
Publicado: (2021)

We are Ready for 2024!
Publicado: (2023)

Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer
por: García-Foncillas, Jesús, et al.
Publicado: (2018)

Efficacy of Image Enhanced Endoscopy for Colorectal Polyps: Are we Ready for Prime Time?
por: Neumann, Helmut, et al.
Publicado: (2017)

Mesenchymal Stem Cells: Are We Ready for Clinical Application in Transplantation and Tissue Regeneration?
por: Hoogduijn, Martin J., et al.
Publicado: (2013)

Controversies in the treatment of RAS wild-type metastatic colorectal cancer
por: Vera, R., et al.
Publicado: (2020)

QCD: are we ready for the LHC?
por: Frixione, Stefano
Publicado: (2006)

Are we ready for submental diversions?
por: Kundra, Pankaj, et al.
Publicado: (2016)

The World is Changing – Are We Ready?
Publicado: (2016)

Pandemic Influenza: Are We Ready?
por: Cinti, Sandro
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_lpgec72dgl9on7hlkstf9b5b4n